NCT00148902View on ClinicalTrials.gov

Effects Of GW572016 In Combination With Docetaxel (TAXOTERE)

PHASE1CompletedINTERVENTIONAL

Enrollment

52

Participants

Timeline

Start Date

April 28, 2003

Primary Completion Date

January 21, 2006

Study Completion Date

January 21, 2006

Conditions

Neoplasms, Breast

Interventions

DRUG

lapatinib

lapatinib

DRUG

docetaxel

docetaxel

Trial Locations (2)

37203

GSK Investigational Site, Nashville

48201

GSK Investigational Site, Detroit

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY